[2-(1,4-dimethylpiperidin-4-yl)-6-methylpyrimidin-4-yl]-[(6R)-6-(quinolin-8-ylmethyl)-1,4-oxazepan-4-yl]methanone

C28H35N5O2 — CID 124952224

IUPAC[2-(1,4-dimethylpiperidin-4-yl)-6-methylpyrimidin-4-yl]-[(6R)-6-(quinolin-8-ylmethyl)-1,4-oxazepan-4-yl]methanone
SMILESCc1cc(C(=O)N2CCOC[C@H](Cc3cccc4cccnc34)C2)nc(C2(C)CCN(C)CC2)n1
InChIInChI=1S/C28H35N5O2/c1-20-16-24(31-27(30-20)28(2)9-12-32(3)13-10-28)26(34)33-14-15-35-19-21(18-33)17-23-7-4-6-22-8-5-11-29-25(22)23/h4-8,11,16,21H,9-10,12-15,17-19H2,1-3H3/t21-/m1/s1
InChIKeyDMXUBNNPDRZYJZ-OAQYLSRUSA-N
MW473.62 g/mol
LogP3.65
Rot. Bonds4

About [2-(1,4-dimethylpiperidin-4-yl)-6-methylpyrimidin-4-yl]-[(6R)-6-(quinolin-8-ylmethyl)-1,4-oxazepan-4-yl]methanone

[2-(1,4-dimethylpiperidin-4-yl)-6-methylpyrimidin-4-yl]-[(6R)-6-(quinolin-8-ylmethyl)-1,4-oxazepan-4-yl]methanone (PubChem CID 124952224) has the molecular formula C28H35N5O2 and a molecular weight of 473.62 g/mol. Its IUPAC name is [2-(1,4-dimethylpiperidin-4-yl)-6-methylpyrimidin-4-yl]-[(6R)-6-(quinolin-8-ylmethyl)-1,4-oxazepan-4-yl]methanone.

Molecular Properties

Compound Name[2-(1,4-dimethylpiperidin-4-yl)-6-methylpyrimidin-4-yl]-[(6R)-6-(quinolin-8-ylmethyl)-1,4-oxazepan-4-yl]methanone
PubChem CID124952224
Molecular FormulaC28H35N5O2
Molecular Weight473.62 g/mol
Exact Mass473.28
IUPAC Name[2-(1,4-dimethylpiperidin-4-yl)-6-methylpyrimidin-4-yl]-[(6R)-6-(quinolin-8-ylmethyl)-1,4-oxazepan-4-yl]methanone
SMILESCc1cc(C(=O)N2CCOC[C@H](Cc3cccc4cccnc34)C2)nc(C2(C)CCN(C)CC2)n1
InChIInChI=1S/C28H35N5O2/c1-20-16-24(31-27(30-20)28(2)9-12-32(3)13-10-28)26(34)33-14-15-35-19-21(18-33)17-23-7-4-6-22-8-5-11-29-25(22)23/h4-8,11,16,21H,9-10,12-15,17-19H2,1-3H3/t21-/m1/s1
InChIKeyDMXUBNNPDRZYJZ-OAQYLSRUSA-N
XLogP3.65
TPSA71.45 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms35
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500473.62
LogP ≤ 53.65
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Analyze [2-(1,4-dimethylpiperidin-4-yl)-6-methylpyrimidin-4-yl]-[(6R)-6-(quinolin-8-ylmethyl)-1,4-oxazepan-4-yl]methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [2-(1,4-dimethylpiperidin-4-yl)-6-methylpyrimidin-4-yl]-[(6R)-6-(quinolin-8-ylmethyl)-1,4-oxazepan-4-yl]methanone?
The IUPAC name of [2-(1,4-dimethylpiperidin-4-yl)-6-methylpyrimidin-4-yl]-[(6R)-6-(quinolin-8-ylmethyl)-1,4-oxazepan-4-yl]methanone (CID 124952224) is [2-(1,4-dimethylpiperidin-4-yl)-6-methylpyrimidin-4-yl]-[(6R)-6-(quinolin-8-ylmethyl)-1,4-oxazepan-4-yl]methanone.
What is the SMILES notation for [2-(1,4-dimethylpiperidin-4-yl)-6-methylpyrimidin-4-yl]-[(6R)-6-(quinolin-8-ylmethyl)-1,4-oxazepan-4-yl]methanone?
The canonical SMILES for [2-(1,4-dimethylpiperidin-4-yl)-6-methylpyrimidin-4-yl]-[(6R)-6-(quinolin-8-ylmethyl)-1,4-oxazepan-4-yl]methanone is Cc1cc(C(=O)N2CCOC[C@H](Cc3cccc4cccnc34)C2)nc(C2(C)CCN(C)CC2)n1.
What is the InChIKey of [2-(1,4-dimethylpiperidin-4-yl)-6-methylpyrimidin-4-yl]-[(6R)-6-(quinolin-8-ylmethyl)-1,4-oxazepan-4-yl]methanone?
The InChIKey is DMXUBNNPDRZYJZ-OAQYLSRUSA-N. The full InChI is InChI=1S/C28H35N5O2/c1-20-16-24(31-27(30-20)28(2)9-12-32(3)13-10-28)26(34)33-14-15-35-19-21(18-33)17-23-7-4-6-22-8-5-11-29-25(22)23/h4-8,11,16,21H,9-10,12-15,17-19H2,1-3H3/t21-/m1/s1.
What are the key properties of [2-(1,4-dimethylpiperidin-4-yl)-6-methylpyrimidin-4-yl]-[(6R)-6-(quinolin-8-ylmethyl)-1,4-oxazepan-4-yl]methanone?
[2-(1,4-dimethylpiperidin-4-yl)-6-methylpyrimidin-4-yl]-[(6R)-6-(quinolin-8-ylmethyl)-1,4-oxazepan-4-yl]methanone has a molecular weight of 473.62 g/mol, XLogP of 3.65, 4 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [2-(1,4-dimethylpiperidin-4-yl)-6-methylpyrimidin-4-yl]-[(6R)-6-(quinolin-8-ylmethyl)-1,4-oxazepan-4-yl]methanone is sourced from PubChem (CID 124952224), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).